Aripiprazole
Aripiprazole +pharma contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. It is used to treat adults and adolescents aged 15 years and older with a disease characterized by symptoms such as: seeing, hearing, and feeling things that are not real, suspiciousness, delusions, disorganized thinking and behavior, and emotional flattening. Patients with these symptoms may also feel depressed, anxious, or tense, and may have feelings of guilt. Aripiprazole +pharma is used to treat adults and adolescents aged 13 years and older with a disease characterized by symptoms such as: excessive excitement, overwhelming energy, reduced need for sleep, very fast speech, racing thoughts, and sometimes severe irritability. In adults, this medicine also prevents the recurrence of these symptoms in patients who have responded to treatment with Aripiprazole +pharma.
Before taking Aripiprazole +pharma, discuss it with your doctor. During treatment with aripiprazole, thoughts and behaviors of suicide have been reported. You should immediately inform your doctor about any thoughts or feelings related to self-harm. Before taking Aripiprazole +pharma, tell your doctor if you have:
If you notice an increase in weight, unusual movements, drowsiness that interferes with daily activities, difficulty swallowing, or signs of an allergic reaction, you should inform your doctor. If an elderly patient has dementia (loss of memory and other mental abilities), the patient, caregiver, or relative should inform the doctor if the patient has ever had a stroke or "mini" stroke. You should immediately inform your doctor about any thoughts or feelings related to self-harm. During treatment with aripiprazole, thoughts and behaviors of suicide have been reported. You should immediately inform your doctor if you experience muscle stiffness or stiffness with high fever, sweating, mental disorders, or very fast or irregular heartbeat. If you or your family or caregiver notice that you are starting to feel the urge or desire to behave in an unusual way and cannot resist the impulse, urge, or temptation to engage in activities that may harm you or others, you should tell your doctor. These phenomena are called impulse control disorders and may manifest as behaviors such as: compulsive gambling, overeating, or excessive spending, excessive sexual drive, or increased frequency and intensity of thoughts or feelings about sex. Your doctor may consider changing the dose or discontinuing the medicine. Aripiprazole may cause drowsiness, decreased blood pressure when standing up, dizziness, and changes in mobility and balance, which can lead to falls. You should be careful, especially in elderly or weakened patients.
This medicine should not be used in children and adolescents under 13 years of age. It is not known if the use of this medicine is safe and effective in these patients.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take, including those obtained without a prescription. Blood pressure-lowering medicines: Aripiprazole +pharma may enhance the effect of blood pressure-lowering medicines. If you are taking blood pressure-lowering medicines, you should inform your doctor. The use of Aripiprazole +pharma with other medicines may require a change in the dose of Aripiprazole +pharma or other medicines you are taking. It is especially important to inform your doctor about the use of the following medicines:
Taking these medicines may increase the risk of side effects or reduce the effect of Aripiprazole +pharma. If you experience any unusual symptoms while taking these medicines with Aripiprazole +pharma, you should inform your doctor. Medicines that increase serotonin levels are usually used to treat depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
Taking these medicines may increase the risk of side effects. If you experience any unusual symptoms while taking these medicines with Aripiprazole +pharma, you should inform your doctor.
Aripiprazole +pharma can be taken with or without food. You should avoid drinking alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. In newborns whose mothers took Aripiprazole +pharma during the last trimester (last 3 months of pregnancy), the following symptoms may occur: trembling, muscle stiffness, and (or) weakness, drowsiness, agitation, difficulty breathing, and difficulty feeding. If you notice any of these symptoms in your baby, you should contact your doctor. If you are taking Aripiprazole +pharma, your doctor will discuss with you whether you should breastfeed, considering the benefits of treatment and the benefits of breastfeeding. You should not take this medicine and breastfeed. You should discuss with your doctor the best methods of feeding your baby if you are taking this medicine.
During treatment with this medicine, dizziness and vision disturbances (see section 4) may occur. You should take this into account when performing tasks that require full attention, such as driving or operating machinery.
If you have been told that you have an intolerance to some sugars, you should contact your doctor before taking this medicine. The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially 'sodium-free'.
This medicine should always be taken exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist. The recommended dose of Aripiprazole +pharma for adults is 15 mg once a day. However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
Treatment may be started with a low dose of aripiprazole in the form of an oral solution (liquid). The dose may be gradually increased to the recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day. If you feel that the effect of Aripiprazole +pharma is too strong or too weak, you should talk to your doctor or pharmacist. Aripiprazole +pharma should be taken once a day at the same time. It does not matter whether the tablet is taken with or without food. The tablet should be swallowed whole and washed down with water. Even if you feel better, you should not change the dose or stop taking Aripiprazole +pharma without first discussing it with your doctor.
If you have taken more Aripiprazole +pharma than your doctor prescribed (or if someone else has taken some of the medicine not intended for them), you should immediately contact your doctor. If you have difficulty contacting your doctor, you should go to the nearest hospital, taking the medicine pack with you. In patients who have taken too much aripiprazole, the following symptoms have occurred:
Other symptoms may include:
If you experience any of these symptoms, you should immediately contact your doctor or hospital.
If you miss a dose, you should take the missed dose as soon as you remember. Do not take two doses on the same day.
You should not stop treatment if you feel better. It is important to take Aripiprazole +pharma for the period prescribed by your doctor. If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Commonside effects (may affect up to 1 in 10 people)
Uncommonside effects (may affect up to 1 in 100 people)
The following side effects have been reported after the marketing of aripiprazole in the form of an oral medicine, but the frequency of their occurrence is unknown(the frequency cannot be determined based on available data):
In elderly patients with dementia, more cases of death have been reported in patients taking aripiprazole. Additionally, cases of stroke or "mini" stroke have been reported.
In adolescents aged 13 years and older, side effects occurred with a similar frequency and type as in adults, except for: drowsiness, uncontrolled trembling, or sudden movements, restlessness, and fatigue, which occurred very frequently (more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle tremors, uncontrolled limb movements, and dizziness, especially when standing up from a lying or sitting position, which occurred frequently (more than 1 in 100 patients).
If you experience any side effects, including those not listed in this leaflet, you should inform your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel: +48 22 49 21 301, fax: +48 22 49 21 309; website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after 'EXP'. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Round, yellow tablets (with possible darker spots), with the inscription "ARZ" and "15" on one side, available in perforated blisters, packaged in cardboard boxes containing 28 or 30 tablets. Not all pack sizes may be marketed.
+pharma arzneimittel gmbh, Hafnerstrasse 211, 8054 Graz, Austria
Synthon Hispania S.L., C/Castelló, 1, Sant Boi de Llobregat, 08830 Barcelona, Spain, Synthon s.r.o., Brněnská 32/čp.597, 678 01 Blansko, Czech Republic, Genericon Pharma Gesellschaft m.b.H., Hafnerstrasse 211, 8054 Graz, Austria
Poland, Aripiprazole +pharma, Czech Republic, Aripiprazol +pharma, Austria, Aripiprazol Genericon 15 mg Tabletten. For more information about this medicine, please contact the representative of the marketing authorization holder: +pharma Polska sp. z o.o., ul. Podgórska 34, 31-536 Kraków, Poland, tel. +48 12 262 32 36, e-mail: krakow@pluspharma.eu. Date of last revision of the leaflet:December 2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.